Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Feb;9(1):15-22.
doi: 10.2174/156652409787314516.

The contribution of gammadelta T cells to the pathogenesis of EAE and MS

Affiliations
Review

The contribution of gammadelta T cells to the pathogenesis of EAE and MS

Sarah E Blink et al. Curr Mol Med. 2009 Feb.

Abstract

Gammadelta T cells are a multifaceted group of cells which have both innate and adaptive characteristics and functions. Although they are most commonly known for their response to mycobacterium and their locations at mucosal sites, their roles in autoimmunity are still unclear. gammadelta T cells have been seen in the CSF and lesions of Multiple Sclerosis patients and although their function is not entirely understood, it is clear these cells may have roles in regulating autoimmune inflammation in the CNS. Recent studies have focused on the role of gammadelta T cells in MS and EAE as both pathogenic and protective, their functions within the CNS, the types of subsets and a possible role in Th17 inflammation. In this review we will examine the data acquired from both human patients and the murine models of MS, experimental autoimmune encephalomyelitis (EAE), in order to gain a clear picture of how gammadelta T cells influence pathogenesis of EAE and MS.

PubMed Disclaimer

References

    1. McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD. J Exp Med. 1995;182:75–85. - PMC - PubMed
    1. Mayr WT, Pittock SJ, McClelland RL, Jorgensen NW, Noseworthy JH, Rodriguez M. Neurology. 2003;61:1373–1377. - PubMed
    1. Kantarci OH, Weinshenker BG. Neurol Clin. 2005;23:17–38. v. - PubMed
    1. Whetten-Goldstein K, Sloan FA, Goldstein LB, Kulas ED. Mult Scler. 1998;4:419–425. - PubMed
    1. Kleinschnitz C, Meuth SG, Stuve O, Kieseier B, Wiendl H. J Neurol. 2007;254:1473–1490. - PubMed

Publication types

MeSH terms

Substances